Skip to content

Randomized Clinical Trial to Determine the Optimal Term of Nasogastric Decompression After Esophagectomy

Randomized Clinical Trial to Determine the Optimal Term of Nasogastric Decompression After Esophagectomy - Randomized Clinical Trial to Determine the Optimal Term of Nasogastric Decompression After Esophagectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017553
Enrollment
80
Registered
2015-05-25
Start date
2015-05-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Group A
Normal nasogastric tube decompression (decannulation on the 7th postoperative day or at the time of contrast esophagram) Group B
Short-term nasogastric tube decompression (decannulation on the 1st postoperative day or at the time of extubation )

Sponsors

School of Medicine, Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Scheduled for esophagectomy 2) Histologically proven esophageal cancer 3) Scheduled for a curative resection 4) Scheduled for right thoracotomy and laparotomy 5) One stage surgery 6) Gastric conduit is selected for reconstruction 7) Posterior mediatinal route is selected for reconstruction 8) Cervical approach is selected for anastomosis 9) severe complication 10) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Apparent infection and/or inflammation 2) Severe complication 3) During pregnancy or desire to bear children 4) Secondary reconstruction 5) Organ other than stomach is selected for reconstruction 6) Antethoracic route is selected for reconstruction 7) Intrapleural anastomosis 8) Over 35 in BMI 9) Under 17.5 in BMI 10) Attending physician's decision

Design outcomes

Primary

MeasureTime frame
Rate of pneumonia

Secondary

MeasureTime frame
Rate of anastomotic leakage, gastrointestinal bleeding Rate of other adverse events Rate of reinsertion of nasogastric tube Rate of recurrent nerve paralysis Swallowing function Respiratory function Postoperative hospital stays

Countries

Japan

Contacts

Public ContactHirofumi Kawakubo

School of Medicine, Keio University Department of Surgery

hkawakubo@z3.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026